首页> 外文期刊>Materials science & engineering, C. Materials for Biogical applications >The use of amphiphilic copolymer in the solid dispersion formulation of nimodipine to inhibit drug crystallization in the release media: Combining nano-drug delivery system with solid preparations
【24h】

The use of amphiphilic copolymer in the solid dispersion formulation of nimodipine to inhibit drug crystallization in the release media: Combining nano-drug delivery system with solid preparations

机译:使用两亲共聚物在尼莫氏脂的固体分散制剂中抑制释放介质中的药物结晶:将纳米药物输送系统与固体制剂相结合

获取原文
获取原文并翻译 | 示例
           

摘要

Solid dispersion is a widely used method to improve the dissolution and oral bioavailability of water-insoluble drugs. However, due to the strong hydrophobicity, the drug crystallization in the release media after drug dissolution and the resulted decreased drug absorption retards the use of solid dispersions. It is widely known that the amphiphilic copolymer can encapsulate the hydrophobic compounds and help form stable nano-dispersions in water. Inspired by this, we tried to formulate the solid dispersion of nimodipine by using amphipathic copolymer as one of the carriers. Concerning the solid dispersions, there are many important points involved in these formulations, such as the miscibility between the drug and the carriers, the storage stability of solid dispersions, the dissolution enhancement and so on. In this study, a systemic method is proposed. In details, the supersaturation test and the glass transition temperature (T-g) measurement to predict the crystallization inhibition, the ratios of different components and the storage stability, the interactions among the components were investigated in detail by nuclear magnetic resonance (H-1 NMR) and isothermal titration calorimetry (ITC) and, the final dissolution and oral bioavailability enhancement. It was found that the amphiphilic copolymer used in the solid dispersion encouraged the formation the drug loading micelles in the release media and, finally, the problem of drug crystallization in the dissolution process was successfully solved.
机译:固体分散体是一种广泛使用的方法,可改善水不溶性药物的溶解和口服生物利用度。然而,由于强烈的疏水性,药物溶解后的释放介质中的药物结晶和导致的药物吸收降低延迟了使用固体分散体。众所周知,两亲性共聚物可以包封疏水化合物并有助于在水中形成稳定的纳米分散体。灵感来自于,我们尝试通过使用两性共聚物作为载体之一来制备尼莫氏脂的固体分散体。关于固体分散体,这些配方中涉及许多重要的观点,例如药物和载体之间的混合物,固体分散体的储存稳定性,溶解增强等。在该研究中,提出了一种系统方法。在细节中,过饱和测试和玻璃化转变温度(Tg)测量以预测结晶抑制,不同组分的比率和储存稳定性,通过核磁共振详细研究了组分之间的相互作用(H-1 NMR)和等温滴定热量法(ITC),最终溶解和口服生物利用度增强。结果发现,在固体分散体中使用的两亲性共聚物促进了释放介质中的药物载体胶束,最后,成功解决了溶解过程中的药物结晶问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号